Results 91 to 100 of about 7,210 (160)

The signs of ocular-surface disorders after switching from latanoprost to tafluprost/timolol fixed combination: a prospective study

Clinical Ophthalmology, 2017
Hideaki Okumichi,1 Yoshiaki Kiuchi,1 Tetsuya Baba,2 Takashi Kanamoto,3 Tomoko Naito,4,5 Shunsuke Nakakura,6 Hitoshi Tabuchi,6 Hiroki Nii,7 Chie Sueoka,7 Yosuke Sugimoto1,8 1Department of Ophthalmology and Visual Science, Graduate School of Biomedical ...
Okumichi H, Kiuchi Y, Baba T, Kanamoto T, Naito T, Nakakura S, Tabuchi H, Nii H, Sueoka C, Sugimoto Y   +9 more
doaj  

Efficacy and safety of a switch to latanoprost 0.005% + timolol maleate 0.5% fixed combination eyedrops from latanoprost 0.005% monotherapy

Clinical Ophthalmology, 2012
Kenji Inoue,1 Takayuki Fujimoto,1 Risako Higa,1 Ryo Moriyama,1 Hiromi Kohmoto,1 Haruka Nagumo,1 Masato Wakakura,1 Goji Tomita21Inouye Eye Hospital, Chiyoda-ku, Tokyo, 2Second Department of Ophthalmology, Toho University School of Medicine, Meguro-ku ...
Inoue K, Fujimoto T, Higa R, Moriyama R, Kohmoto H, Nagumo H, Wakakura M, Tomita G   +7 more
doaj  

New glaucoma medications: latanoprostene bunod, netarsudil, and fixed combination netarsudil-latanoprost

Eye, 2019
Nikki A. Mehran, Sapna Sinha, Reza Razeghinejad   +2 more
semanticscholar   +1 more source

Periorbital skin hypopigmentation associated with the use of topical glaucoma medications. [PDF]

Digit J Ophthalmol
Karimaghaei S, Yee J, Elhusseiny AM.
europepmc   +1 more source

Development of a conjunctival contact-type drug delivery device for latanoprost using hyaluronic acid. [PDF]

Drug Deliv
Lee S, Jung MY, Park CY.
europepmc   +1 more source

Comparative Efficacy and Safety of Netarsudil-Containing Interventions for Intraocular Pressure Control: A Systematic Review and Network Meta-Analysis. [PDF]

Cureus
Awan B, Elsaigh M, Tariq A, Badee M.
europepmc   +1 more source

Cystoid Macular Edema Related to Uncomplicated Cataract Surgery and Topical Prostaglandin Analogs: A Systematic Review of Randomized Controlled Trials. [PDF]

Cureus
Santamaria AB, Vera L, Rebollo F, Hartleben-Matkin C.   +3 more
europepmc   +1 more source

Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: 3-Month Data From a Randomized Phase 3 Trial.

American journal of ophthalmology-glaucoma, 2019
S. Asrani, A. Robin, J. Serle, R. Lewis, D. Usner, C. Kopczynski, T. Heah   +6 more
semanticscholar   +1 more source

Association of Matrix Metalloproteinases Polymorphisms with Glaucoma Risk, Glaucoma Phenotype, and Response to Treatment with Selective Laser Trabeculoplasty or Latanoprost. [PDF]

Int J Mol Sci
Atanasovska Velkovska M, Goričar K, Blagus T, Dolžan V, Cvenkel B.   +4 more
europepmc   +1 more source

Once-Daily Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure in the Randomized Phase 3 MERCURY-2 Study.

Ophthalmology Glaucoma, 2019
T. Walters, I. Ahmed, R. Lewis, D. Usner, Jae Lopez, C. Kopczynski, T. Heah   +6 more
semanticscholar   +1 more source